FDA Develops Alternative Assay to Increase Availability of Influenza Vaccines

A laboratory assay developed by scientists at FDA could speed the release of pandemic influenza vaccines to the public by shortening the time it takes to test vaccine potency. The FDA scientists developed the new assay in response to the recommendation of a workshop organized by the World HealOriginal Article